Literature DB >> 3473422

Extracellular proteinaceous substances from Haemophilus actinomycetemcomitans induce mitogenic responses in murine lymphocytes.

T Nishihara, T Koga, S Hamada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3473422     DOI: 10.1111/j.1399-302x.1987.tb00269.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


× No keyword cloud information.
  6 in total

1.  A novel factor isolated from Actinobacillus actinomycetemcomitans stimulates mouse B cells and human peripheral blood mononuclear cells.

Authors:  S J Jeong; S T Yee; W S Jo; S H Yu; S H Lee; Y J Lim; Y H Yoo; J M Kim; J D Lee; M H Jeong
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and apoptosis.

Authors:  M Ohguchi; A Ishisaki; N Okahashi; M Koide; T Koseki; K Yamato; T Noguchi; T Nishihara
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

3.  Immunochemical and structural characterization of a serotype-specific polysaccharide antigen from Actinobacillus actinomycetemcomitans Y4 (serotype b).

Authors:  K Amano; T Nishihara; N Shibuya; T Noguchi; T Koga
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

4.  Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

5.  Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans.

Authors:  T Takahashi; T Nishihara; Y Ishihara; K Amano; N Shibuya; I Moro; T Koga
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

6.  Suppression of murine macrophage interleukin-1 release by the polysaccharide portion of Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.